In the OASIS 1 trial, adults with overweight or obesity took oral semaglutide 50 mg once daily for 68 weeks
Pre-existing b12 deficiency or low-normal levels Anyone starting semaglutide with documented b12 deficiency or levels in the low-normal range (200 to 400 pg per milliliter) should receive supplementation
The FDA also warns not to take Ozempic if you have or have a family history of multiple endocrine neoplasia syndrome Type 2 or medullary thyroid cancer
Resources include the patient information leaflet with step-by-step instructions, instructional videos on the Ozempic website, your pharmacist can demonstrate technique, your providers office may offer injection training, and our injection guide walks through the process
The lack of human safety data creates uncertainty, but uncertainty is not the same as known danger
The habits you build during treatment determine long-term success